Use of exogenous gangliosides in tumoral diseases as a...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

167/199

A61K 31/70 (2006.01) A61K 33/24 (2006.01)

Patent

CA 1314219

Abstract of the Disclosure A novel agent is provided herein for the prevention or prophylaxis of general toxic effects or chronic neurotoxic effects which are caused by the administration of antineoplastic agents, which is to be given to patients prior to administration of said antineoplastic agents and which comprises as an active ingredient a mixture of gangliosides GM1, GD1a, GD1b and GT1b.

540885

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of exogenous gangliosides in tumoral diseases as a... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of exogenous gangliosides in tumoral diseases as a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of exogenous gangliosides in tumoral diseases as a... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1318392

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.